Symbols / KMTS Stock $21.66 -2.56% Kestra Medical Technologies, Ltd.
KMTS (Stock) Chart
Stock Fundamentals
|
|
|
|
|
|
About
Kestra Medical Technologies, Ltd. operates as a wearable medical device and digital healthcare company. It focuses on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. The company's develops and commercializes Cardiac Recovery System platform, a system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution. Its platform provides ASSURE WCD, a wearable cardioverter defibrillator used to protect patients at an elevated risk of sudden cardiac arrest; and a suite of integrated digital solutions and services that enable enhanced patient and provider engagement and oversight with the objective of improving patient outcomes. The company was founded in 2014 and is based in Kirkland, Washington.
Ratings
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2026-04-09 | main | Goldman Sachs | Neutral → Neutral | $17 |
| 2026-04-07 | reit | BTIG | Buy → Buy | $32 |
| 2026-03-25 | reit | BTIG | Buy → Buy | $32 |
| 2026-03-18 | reit | BTIG | Buy → Buy | $32 |
| 2025-12-15 | main | Goldman Sachs | Neutral → Neutral | $25 |
| 2025-12-12 | main | Wells Fargo | Overweight → Overweight | $28 |
| 2025-12-12 | main | Piper Sandler | Overweight → Overweight | $30 |
| 2025-11-18 | init | BTIG | — → Buy | $32 |
| 2025-07-17 | main | Wells Fargo | Overweight → Overweight | $27 |
| 2025-04-16 | main | Goldman Sachs | Neutral → Neutral | $23 |
| 2025-03-31 | init | Wolfe Research | — → Outperform | $29 |
| 2025-03-31 | init | Wells Fargo | — → Overweight | $28 |
| 2025-03-31 | init | Stifel | — → Buy | $28 |
| 2025-03-31 | init | Goldman Sachs | — → Neutral | $24 |
| 2025-03-31 | init | Piper Sandler | — → Overweight | $27 |
- Assessing Kestra Medical Technologies (KMTS) Valuation After Recent Share Price Momentum - simplywall.st ue, 28 Apr 2026 17
- (KMTS) Risk Channels and Responsive Allocation - Stock Traders Daily ue, 28 Apr 2026 12
- Webster, Kestra Medical CEO, sells $300k in KMTS stock - Investing.com hu, 16 Apr 2026 07
- Kestra Medical Technologies (NASDAQ:KMTS) Stock Price Down 7.2% on Analyst Downgrade - MarketBeat Fri, 10 Apr 2026 07
- Kestra brings an FDA-approved wearable defibrillator upgrade to Chicago - Stock Titan Wed, 22 Apr 2026 12
- Assessing Kestra Medical Technologies (KMTS) Valuation After Recent Share Price Weakness - Yahoo Finance Sat, 28 Mar 2026 07
- KESTRA MEDICAL TECHNOLOGIES ($KMTS) Releases Q3 2026 Earnings, Stock Rises - Quiver Quantitative ue, 17 Mar 2026 07
- Pre-Market Movements | Multiple Factors Affect KMTS.US Stock Price变动 - 富途牛牛 Fri, 24 Apr 2026 13
- Kestra Medical Technologies (KMTS) Stock Analysis: Exploring a Promising 16.84% Upside in the Healthcare Sector - DirectorsTalk Interviews ue, 27 Jan 2026 08
- Three 15,000-share sales reported for Kestra Medical Technologies (NASDAQ: KMTS) - Stock Titan Wed, 15 Apr 2026 07
- Webster, Kestra Medical CEO, sells $300k in KMTS stock By Investing.com - Investing.com South Africa hu, 16 Apr 2026 21
- Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) Given Average Rating of "Hold" by Analysts - MarketBeat Fri, 10 Apr 2026 07
- Institutions along with private equity firms who hold considerable shares inKestra Medical Technologies, Ltd. (NASDAQ:KMTS) come under pressure; lose 6.5% of holdings value - Yahoo Finance Sun, 18 Jan 2026 08
- Employee survey puts Kestra Medical on USA TODAY Top Workplaces list - Stock Titan hu, 09 Apr 2026 07
- Kestra Medical Technologies Inc Stock Price Today | NASDAQ: KMTS Live - Investing.com ue, 17 Mar 2026 07
Insider Transactions
Financials
| Line Item | Trend | 2025-04-30 | 2024-04-30 | 2023-04-30 | 2021-04-30 |
|---|---|---|---|---|---|
| Total Revenue |
|
59.81
+115.05%
|
27.81
+264.53%
|
7.63
|
0.00
|
| Operating Revenue |
|
59.81
+115.05%
|
27.81
+264.53%
|
7.63
|
0.00
|
| Cost Of Revenue |
|
35.60
+29.70%
|
27.45
+50.17%
|
18.28
|
—
|
| Reconciled Cost Of Revenue |
|
35.60
+29.70%
|
27.45
+50.17%
|
18.28
|
—
|
| Gross Profit |
|
24.21
+6587.85%
|
0.36
+103.40%
|
-10.65
|
—
|
| Operating Expense |
|
130.59
+52.87%
|
85.42
+22.44%
|
69.77
+113.31%
|
32.71
|
| Research And Development |
|
15.65
+1.05%
|
15.49
-1.69%
|
15.76
-16.22%
|
18.81
|
| Selling General And Administration |
|
114.94
+64.35%
|
69.94
+29.48%
|
54.01
+288.53%
|
13.90
|
| Selling And Marketing Expense |
|
—
|
40.68
+16.50%
|
34.92
+151.18%
|
13.90
|
| Total Expenses |
|
166.19
+47.23%
|
112.88
+28.20%
|
88.05
+169.20%
|
32.71
|
| Operating Income |
|
-106.38
-25.06%
|
-85.06
-5.77%
|
-80.42
-145.88%
|
-32.71
|
| Total Operating Income As Reported |
|
-106.38
-25.06%
|
-85.06
-5.77%
|
-80.42
-145.88%
|
-32.71
|
| EBITDA |
|
-97.98
-28.40%
|
-76.31
-3.48%
|
-73.74
-128.11%
|
-32.33
|
| Normalized EBITDA |
|
-95.33
-24.93%
|
-76.31
-3.48%
|
-73.74
-128.11%
|
-32.33
|
| Reconciled Depreciation |
|
7.97
-31.07%
|
11.56
+138.11%
|
4.86
+1055.95%
|
0.42
|
| EBIT |
|
-105.94
-20.58%
|
-87.87
-11.80%
|
-78.59
-140.01%
|
-32.75
|
| Total Unusual Items |
|
-2.65
|
—
|
—
|
—
|
| Total Unusual Items Excluding Goodwill |
|
-2.65
|
—
|
—
|
—
|
| Net Income |
|
-113.81
-20.92%
|
-94.12
-11.73%
|
-84.24
-147.03%
|
-34.10
|
| Pretax Income |
|
-113.68
-20.81%
|
-94.10
-11.72%
|
-84.22
-148.34%
|
-33.91
|
| Net Non Operating Interest Income Expense |
|
-4.54
+27.21%
|
-6.23
-10.68%
|
-5.63
-381.93%
|
-1.17
|
| Interest Expense Non Operating |
|
7.73
+24.14%
|
6.23
+10.68%
|
5.63
+381.93%
|
1.17
|
| Net Interest Income |
|
-4.54
+27.21%
|
-6.23
-10.68%
|
-5.63
-381.93%
|
-1.17
|
| Interest Expense |
|
7.73
+24.14%
|
6.23
+10.68%
|
5.63
+381.93%
|
1.17
|
| Interest Income Non Operating |
|
3.20
|
0.00
|
—
|
—
|
| Interest Income |
|
3.20
|
0.00
|
—
|
—
|
| Other Income Expense |
|
-2.77
+1.32%
|
-2.80
-253.42%
|
1.83
+4907.89%
|
-0.04
|
| Other Non Operating Income Expenses |
|
-0.12
+95.79%
|
-2.80
-253.42%
|
1.83
+4907.89%
|
-0.04
|
| Gain On Sale Of Security |
|
-2.65
|
—
|
—
|
—
|
| Tax Provision |
|
0.14
+462.50%
|
0.02
+60.00%
|
0.01
-91.98%
|
0.19
|
| Tax Rate For Calcs |
|
0.00
+0.00%
|
0.00
+0.00%
|
0.00
-22.22%
|
0.00
|
| Tax Effect Of Unusual Items |
|
-0.56
|
0.00
|
0.00
|
0.00
|
| Net Income Including Noncontrolling Interests |
|
-113.81
-20.92%
|
-94.12
-11.73%
|
-84.24
-147.03%
|
-34.10
|
| Net Income From Continuing Operation Net Minority Interest |
|
-113.81
-20.92%
|
-94.12
-11.73%
|
-84.24
-147.03%
|
-34.10
|
| Net Income From Continuing And Discontinued Operation |
|
-113.81
-20.92%
|
-94.12
-11.73%
|
-84.24
-147.03%
|
-34.10
|
| Net Income Continuous Operations |
|
-113.81
-20.92%
|
-94.12
-11.73%
|
-84.24
-147.03%
|
-34.10
|
| Minority Interests |
|
—
|
0.69
|
0.00
|
—
|
| Normalized Income |
|
-111.72
-18.70%
|
-94.12
-11.73%
|
-84.24
-147.03%
|
-34.10
|
| Net Income Common Stockholders |
|
-126.14
-25.08%
|
-100.84
-16.26%
|
-86.74
-154.35%
|
-34.10
|
| Diluted EPS |
|
-5.13
-1.16%
|
-5.07
-16.26%
|
-4.36
-154.35%
|
-1.71
|
| Basic EPS |
|
-5.13
-1.16%
|
-5.07
-16.26%
|
-4.36
-154.35%
|
-1.71
|
| Basic Average Shares |
|
24.58
+23.63%
|
19.89
+0.00%
|
19.89
+0.00%
|
19.89
|
| Diluted Average Shares |
|
24.58
+23.63%
|
19.89
+0.00%
|
19.89
+0.00%
|
19.89
|
| Diluted NI Availto Com Stockholders |
|
-126.14
-25.08%
|
-100.84
-16.26%
|
-86.74
-154.35%
|
-34.10
|
| Preferred Stock Dividends |
|
12.32
+83.32%
|
6.72
+168.95%
|
2.50
|
—
|
| Line Item | Trend | 2025-04-30 | 2024-04-30 | 2023-04-30 | 2021-04-30 |
|---|---|---|---|---|---|
| Total Assets |
|
295.74
+543.64%
|
45.95
+18.87%
|
38.66
+26.65%
|
30.52
|
| Current Assets |
|
255.33
+1612.81%
|
14.91
-19.08%
|
18.42
-29.67%
|
26.20
|
| Cash Cash Equivalents And Short Term Investments |
|
237.59
+2780.29%
|
8.25
-44.30%
|
14.81
-39.16%
|
24.34
|
| Cash And Cash Equivalents |
|
237.59
+2780.29%
|
8.25
-44.30%
|
14.81
-39.16%
|
24.34
|
| Receivables |
|
8.08
+304.45%
|
2.00
|
0.00
|
—
|
| Accounts Receivable |
|
8.08
+304.45%
|
2.00
|
0.00
|
—
|
| Other Receivables |
|
—
|
3.29
+55.70%
|
2.11
|
—
|
| Inventory |
|
6.57
+99.76%
|
3.29
+55.70%
|
2.11
|
—
|
| Prepaid Assets |
|
1.39
+45.85%
|
0.95
-15.84%
|
1.13
+122.00%
|
0.51
|
| Other Current Assets |
|
1.69
+304.06%
|
0.42
+13.24%
|
0.37
-72.49%
|
1.34
|
| Total Non Current Assets |
|
40.42
+30.20%
|
31.04
+53.42%
|
20.23
+367.71%
|
4.33
|
| Net PPE |
|
36.91
+30.00%
|
28.39
+69.77%
|
16.72
+442.43%
|
3.08
|
| Gross PPE |
|
60.86
+32.49%
|
45.94
+92.34%
|
23.88
+414.72%
|
4.64
|
| Accumulated Depreciation |
|
-23.95
-36.53%
|
-17.55
-145.06%
|
-7.16
-359.86%
|
-1.56
|
| Properties |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Machinery Furniture Equipment |
|
1.45
+0.49%
|
1.44
-2.18%
|
1.47
+63.44%
|
0.90
|
| Construction In Progress |
|
0.64
-61.75%
|
1.66
|
—
|
—
|
| Other Properties |
|
57.86
+37.94%
|
41.95
+94.74%
|
21.54
+547.62%
|
3.33
|
| Leases |
|
0.92
+3.14%
|
0.89
+2.18%
|
0.87
+110.63%
|
0.41
|
| Non Current Prepaid Assets |
|
2.02
+18.19%
|
1.71
-35.28%
|
2.64
|
—
|
| Other Non Current Assets |
|
1.49
+58.02%
|
0.94
+8.41%
|
0.87
-30.17%
|
1.24
|
| Total Liabilities Net Minority Interest |
|
90.34
-64.62%
|
255.33
+63.43%
|
156.23
+443.31%
|
28.76
|
| Current Liabilities |
|
37.98
+15.18%
|
32.97
-10.26%
|
36.74
+455.98%
|
6.61
|
| Payables And Accrued Expenses |
|
29.12
+8.74%
|
26.78
+160.96%
|
10.26
+84.98%
|
5.55
|
| Payables |
|
23.96
+0.29%
|
23.89
+287.73%
|
6.16
+253.93%
|
1.74
|
| Accounts Payable |
|
23.96
+0.29%
|
23.89
+287.73%
|
6.16
+262.68%
|
1.70
|
| Current Accrued Expenses |
|
5.16
+78.72%
|
2.88
-29.62%
|
4.10
+7.70%
|
3.81
|
| Pensionand Other Post Retirement Benefit Plans Current |
|
8.67
+40.02%
|
6.19
+32.75%
|
4.67
|
—
|
| Total Tax Payable |
|
—
|
0.23
+8.84%
|
0.21
+411.90%
|
0.04
|
| Current Debt And Capital Lease Obligation |
|
0.19
|
—
|
21.81
+1955.80%
|
1.06
|
| Current Debt |
|
—
|
—
|
20.45
|
—
|
| Other Current Borrowings |
|
—
|
—
|
20.45
|
—
|
| Current Capital Lease Obligation |
|
0.19
|
0.00
-100.00%
|
1.37
+28.75%
|
1.06
|
| Other Current Liabilities |
|
—
|
4.55
-15.27%
|
5.38
|
—
|
| Total Non Current Liabilities Net Minority Interest |
|
52.36
-76.45%
|
222.35
+86.08%
|
119.50
+439.53%
|
22.15
|
| Long Term Debt And Capital Lease Obligation |
|
44.12
-2.31%
|
45.17
+160.76%
|
17.32
-20.50%
|
21.79
|
| Long Term Debt |
|
41.10
-3.38%
|
42.54
+145.56%
|
17.32
-14.41%
|
20.24
|
| Long Term Capital Lease Obligation |
|
3.03
+14.93%
|
2.63
|
0.00
-100.00%
|
1.55
|
| Other Non Current Liabilities |
|
0.14
+84.21%
|
0.08
+20.63%
|
0.06
-82.50%
|
0.36
|
| Preferred Securities Outside Stock Equity |
|
0.00
-100.00%
|
177.11
+73.45%
|
102.11
|
—
|
| Stockholders Equity |
|
205.41
+198.10%
|
-209.38
-78.07%
|
-117.58
-6757.87%
|
1.77
|
| Common Stock Equity |
|
205.41
+198.10%
|
-209.38
-78.07%
|
-117.58
-6757.87%
|
1.77
|
| Capital Stock |
|
51.35
+157.92%
|
19.91
+1990800.00%
|
0.00
+0.00%
|
0.00
|
| Common Stock |
|
51.35
+157.92%
|
19.91
+1990800.00%
|
0.00
+0.00%
|
0.00
|
| Share Issued |
|
51.35
+3.66%
|
49.53
+0.00%
|
49.53
+0.00%
|
49.53
|
| Ordinary Shares Number |
|
51.35
+3.66%
|
49.53
+0.00%
|
49.53
+0.00%
|
49.53
|
| Additional Paid In Capital |
|
674.31
+280.64%
|
177.15
-9.03%
|
194.74
+13.32%
|
171.84
|
| Retained Earnings |
|
-520.25
-28.00%
|
-406.44
-30.14%
|
-312.31
-83.63%
|
-170.08
|
| Total Equity Gross Minority Interest |
|
205.41
+198.10%
|
-209.38
-78.07%
|
-117.58
-6757.87%
|
1.77
|
| Total Capitalization |
|
246.50
+247.75%
|
-166.84
-66.41%
|
-100.26
-555.63%
|
22.00
|
| Working Capital |
|
217.35
+1303.23%
|
-18.06
+1.38%
|
-18.32
-193.51%
|
19.59
|
| Invested Capital |
|
246.50
+247.75%
|
-166.84
-109.05%
|
-79.81
-462.71%
|
22.00
|
| Total Debt |
|
44.31
-1.90%
|
45.17
+15.42%
|
39.13
+71.27%
|
22.85
|
| Net Debt |
|
—
|
34.29
+49.35%
|
22.96
|
—
|
| Capital Lease Obligations |
|
3.21
+22.03%
|
2.63
+92.75%
|
1.37
-47.68%
|
2.61
|
| Net Tangible Assets |
|
205.41
+198.10%
|
-209.38
-78.07%
|
-117.58
-6757.87%
|
1.77
|
| Tangible Book Value |
|
205.41
+198.10%
|
-209.38
-78.07%
|
-117.58
-6757.87%
|
1.77
|
| Derivative Product Liabilities |
|
8.10
|
0.00
|
—
|
—
|
| Line Item | Trend | 2025-04-30 | 2024-04-30 | 2023-04-30 | 2021-04-30 |
|---|---|---|---|---|---|
| Operating Cash Flow |
|
-77.61
-7.44%
|
-72.23
-3.72%
|
-69.64
-132.96%
|
-29.89
|
| Cash Flow From Continuing Operating Activities |
|
-77.61
-7.44%
|
-72.23
-3.72%
|
-69.64
-132.96%
|
-29.89
|
| Net Income From Continuing Operations |
|
-113.81
-20.92%
|
-94.12
-11.73%
|
-84.24
-147.03%
|
-34.10
|
| Depreciation Amortization Depletion |
|
7.97
-31.07%
|
11.56
+138.11%
|
4.86
+1055.95%
|
0.42
|
| Depreciation |
|
—
|
11.56
+138.11%
|
4.86
+1055.95%
|
0.42
|
| Depreciation And Amortization |
|
7.97
-31.07%
|
11.56
+138.11%
|
4.86
+1055.95%
|
0.42
|
| Other Non Cash Items |
|
2.67
+9.60%
|
2.44
-63.73%
|
6.72
+252.89%
|
1.90
|
| Stock Based Compensation |
|
24.27
+1531.05%
|
1.49
+23.08%
|
1.21
-35.10%
|
1.86
|
| Provisionand Write Offof Assets |
|
2.69
+438.80%
|
0.50
|
—
|
—
|
| Deferred Tax |
|
0.06
+433.33%
|
0.01
+126.67%
|
-0.04
|
—
|
| Deferred Income Tax |
|
0.06
+433.33%
|
0.01
+126.67%
|
-0.04
|
—
|
| Operating Gains Losses |
|
4.74
+137.10%
|
2.00
+257.14%
|
0.56
+1373.68%
|
0.04
|
| Gain Loss On Investment Securities |
|
2.65
|
—
|
—
|
0.04
|
| Gain Loss On Sale Of PPE |
|
2.09
+95.70%
|
1.07
+91.07%
|
0.56
|
—
|
| Change In Working Capital |
|
-6.20
-259.54%
|
3.89
+199.54%
|
1.30
+6931.58%
|
-0.02
|
| Change In Receivables |
|
-8.78
-251.36%
|
-2.50
|
0.00
|
—
|
| Changes In Account Receivables |
|
-8.78
-251.36%
|
-2.50
|
0.00
|
—
|
| Change In Inventory |
|
-3.44
-192.52%
|
-1.18
-60.57%
|
-0.73
|
—
|
| Change In Prepaid Assets |
|
-1.85
-659.52%
|
0.33
+222.14%
|
-0.27
+81.21%
|
-1.44
|
| Change In Payables And Accrued Expense |
|
7.46
-3.27%
|
7.71
+125.01%
|
3.43
+73.08%
|
1.98
|
| Change In Accrued Expense |
|
4.62
+1144.47%
|
0.37
-71.11%
|
1.28
-39.20%
|
2.11
|
| Change In Payable |
|
2.84
-61.28%
|
7.34
+242.51%
|
2.14
+1723.48%
|
-0.13
|
| Change In Account Payable |
|
2.84
-61.28%
|
7.34
+242.51%
|
2.14
+1723.48%
|
-0.13
|
| Change In Other Current Assets |
|
0.04
+500.00%
|
-0.01
-162.50%
|
0.02
-72.88%
|
0.06
|
| Change In Other Current Liabilities |
|
0.37
+178.89%
|
-0.47
+58.90%
|
-1.14
-85.23%
|
-0.62
|
| Investing Cash Flow |
|
-23.31
-90.60%
|
-12.23
+20.90%
|
-15.46
-4529.04%
|
-0.33
|
| Cash Flow From Continuing Investing Activities |
|
-23.31
-90.60%
|
-12.23
+20.90%
|
-15.46
-4529.04%
|
-0.33
|
| Net PPE Purchase And Sale |
|
-23.59
-88.52%
|
-12.51
+19.06%
|
-15.46
-4529.04%
|
-0.33
|
| Purchase Of PPE |
|
-23.59
-88.52%
|
-12.51
+19.06%
|
-15.46
-4501.49%
|
-0.34
|
| Sale Of PPE |
|
—
|
—
|
—
|
0.00
|
| Capital Expenditure |
|
-23.59
-88.52%
|
-12.51
+19.06%
|
-15.46
-4501.49%
|
-0.34
|
| Net Other Investing Changes |
|
0.28
-0.70%
|
0.28
|
—
|
—
|
| Financing Cash Flow |
|
330.26
+324.91%
|
77.72
-19.13%
|
96.11
+96.88%
|
48.81
|
| Cash Flow From Continuing Financing Activities |
|
330.26
+324.91%
|
77.72
-19.13%
|
96.11
+96.88%
|
48.81
|
| Net Issuance Payments Of Debt |
|
0.00
-100.00%
|
5.88
+210.20%
|
-5.33
-126.67%
|
20.00
|
| Issuance Of Debt |
|
0.00
-100.00%
|
45.00
|
0.00
-100.00%
|
20.00
|
| Repayment Of Debt |
|
0.00
+100.00%
|
-39.12
-633.60%
|
-5.33
|
—
|
| Long Term Debt Issuance |
|
0.00
-100.00%
|
45.00
|
0.00
-100.00%
|
20.00
|
| Long Term Debt Payments |
|
0.00
+100.00%
|
-39.12
-633.60%
|
-5.33
|
—
|
| Net Long Term Debt Issuance |
|
0.00
-100.00%
|
5.88
+210.20%
|
-5.33
-126.67%
|
20.00
|
| Net Common Stock Issuance |
|
215.79
|
0.00
|
—
|
—
|
| Cash Dividends Paid |
|
-1.65
-107.01%
|
-0.80
-19.08%
|
-0.67
-258.82%
|
-0.19
|
| Net Other Financing Charges |
|
12.73
+640.88%
|
-2.35
|
—
|
29.00
|
| Changes In Cash |
|
229.35
+3503.26%
|
-6.74
-161.25%
|
11.00
-40.80%
|
18.59
|
| Beginning Cash Position |
|
8.58
-43.98%
|
15.32
+254.76%
|
4.32
-31.09%
|
6.27
|
| End Cash Position |
|
237.93
+2672.10%
|
8.58
-43.98%
|
15.32
-38.35%
|
24.85
|
| Free Cash Flow |
|
-101.20
-19.41%
|
-84.75
+0.42%
|
-85.10
-181.51%
|
-30.23
|
| Interest Paid Supplemental Data |
|
—
|
3.63
|
0.00
|
—
|
| Income Tax Paid Supplemental Data |
|
—
|
0.04
+258.33%
|
0.01
-94.39%
|
0.21
|
| Common Stock Issuance |
|
215.79
|
0.00
|
—
|
—
|
| Issuance Of Capital Stock |
|
319.19
+325.59%
|
75.00
-26.55%
|
102.11
|
—
|
| Net Preferred Stock Issuance |
|
103.40
+37.87%
|
75.00
-26.55%
|
102.11
|
—
|
| Preferred Stock Issuance |
|
103.40
+37.87%
|
75.00
-26.55%
|
102.11
|
—
|
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
- 42026-04-16 View
- 42026-03-30 View
- 42026-03-19 View
- 10-Q2026-03-17 View
- 8-K2026-03-17 View
- 42026-03-12 View
- 42026-02-19 View
- 42026-01-20 View
- 42025-12-31 View
- 42025-12-31 View
- 10-Q2025-12-11 View
- 8-K2025-12-11 View
- 42025-12-04 View
- 8-K2025-12-04 View
- 8-K2025-12-01 View
- 8-K2025-11-10 View
- 10-Q2025-09-12 View
- 8-K2025-09-11 View
- 42025-09-08 View
- 42025-09-08 View
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|